Chemoinformaics analysis of 2-BENZYL-3H-QUINAZOLIN-4-ONE
| Molecular Weight | 236.274 | nRot | 2 |
| Heavy Atom Molecular Weight | 224.178 | nRig | 12 |
| Exact Molecular Weight | 236.095 | nRing | 3 |
| Solubility: LogS | -4.4 | nHRing | 1 |
| Solubility: LogP | 3.555 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 30 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 18 | No. of Aromatic Carbocycles | 2 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 17 |
| nHA | 2 | APOL | 36.0535 |
| nHD | 1 | BPOL | 14.6165 |
| QED | 0.768 |
| Synth | 1.403 |
| Natural Product Likeliness | -1.43 |
| NR-PPAR-gamma | 0.009 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.105 |
| Pgp-sub | 0.001 |
| HIA | 0.003 |
| CACO-2 | -4.555 |
| MDCK | 0.0000331 |
| BBB | 0.664 |
| PPB | 0.989501 |
| VDSS | 0.886 |
| FU | 0.0267667 |
| CYP1A2-inh | 0.974 |
| CYP1A2-sub | 0.686 |
| CYP2c19-inh | 0.95 |
| CYP2c19-sub | 0.067 |
| CYP2c9-inh | 0.799 |
| CYP2c9-sub | 0.589 |
| CYP2d6-inh | 0.068 |
| CYP2d6-sub | 0.372 |
| CYP3a4-inh | 0.041 |
| CYP3a4-sub | 0.291 |
| CL | 11.877 |
| T12 | 0.13 |
| hERG | 0.16 |
| Ames | 0.297 |
| ROA | 0.026 |
| SkinSen | 0.165 |
| Carcinogencity | 0.739 |
| EI | 0.767 |
| Respiratory | 0.103 |
| NR-Aromatase | 0.098 |
| Antiviral | Yes |
| Prediction | 0.729945 |